Identification and validation of key extracellular proteins as the potential biomarkers in diabetic nephropathy
- PMID: 39456069
- PMCID: PMC11515200
- DOI: 10.1186/s40001-024-02120-y
Identification and validation of key extracellular proteins as the potential biomarkers in diabetic nephropathy
Abstract
Objective: Accumulation of extracellular matrix (ECM) proteins in the glomerular mesangial region is a typical hallmark of diabetic nephropathy (DN). However, the molecular mechanism underlying ECM accumulation in the mesangium of DN patients remains unclear. The present study aims to establish a connection between extracellular proteins and DN with the goal of identifying potential biomarkers for this condition.
Methods: Differentially expressed genes (DEGs) between DN kidney tissue and healthy kidney tissue were analyzed using the public data GSE166239. Two gene lists encoding extracellular proteins were then utilized to identify extracellular protein-differentially expressed genes (EP-DEGs). Functional enrichment analyses, including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, were performed on these EP-DEGs. A protein-protein interaction (PPI) network was established to identify key EP-DEGs. Furthermore, the diagnostic ability, immune cell infiltration, and clinical relevance of these EP-DEGs were investigated. Immunohistochemistry (IHC) staining of paraffin-embedded renal tissues was performed to validate the accuracy of the bioinformatic results.
Results: A total of 1204 DEGs were identified, from which 162 EP-DEGs were further characterized by overlapping with extracellular protein gene lists. From the PPI network analysis, five EP-DEGs (e.g., TNF, COL1A1, FN1, MMP9, and TGFB1) were identified as candidate biomarkers. TNF, COL1A1, and MMP9 had a high diagnostic accuracy for DN. Assessment of immune cell infiltration revealed that the expression of TNF was positively associated with resting dendritic cells (DCs) (r = 0.85, P < 0.001) and M1 macrophages (r = 0.62, P < 0.05), whereas negatively associated with regulatory T cells (r = - 0.62, P < 0.05). Nephroseq v5 analysis demonstrated a negative correlation between the estimated glomerular filtration rate (eGFR) and TNF expression (r = - 0.730, P = 0.025). Gene set enrichment analysis (GSEA) revealed significant enrichment of glycosaminoglycan (GAG) degradation in the high-TNF subgroup. IHC staining of renal tissues confirmed significantly elevated TNF-a expression and decreased hyaluronic acid (HA) levels in the DN group compared to controls (both P < 0.05), with a negative correlation observed between TNF-a and HA (r = - 0.691, P = 0.026).
Conclusion: Our findings suggest that TNF may play a pivotal role in the progress of DN by driving ECM accumulation, and this process might involve GAG degradation pathway activation.
Keywords: Dendritic cell; Diabetic nephropathy; Extracellular matrix; Glycosaminoglycan degradation; TNF.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures










Similar articles
-
Identification of Lipotoxicity-Related Biomarkers in Diabetic Nephropathy Based on Bioinformatic Analysis.J Diabetes Res. 2024 May 14;2024:5550812. doi: 10.1155/2024/5550812. eCollection 2024. J Diabetes Res. 2024. PMID: 38774257 Free PMC article.
-
Integrating bioinformatics and machine learning to identify glomerular injury genes and predict drug targets in diabetic nephropathy.Sci Rep. 2025 May 15;15(1):16868. doi: 10.1038/s41598-025-01628-5. Sci Rep. 2025. PMID: 40374840 Free PMC article.
-
Lumican as a potential biomarker for diabetic nephropathy.Ren Fail. 2025 Dec;47(1):2480245. doi: 10.1080/0886022X.2025.2480245. Epub 2025 Apr 7. Ren Fail. 2025. PMID: 40195568 Free PMC article.
-
Machine learning based identification of anoikis related gene classification patterns and immunoinfiltration characteristics in diabetic nephropathy.Sci Rep. 2025 May 1;15(1):15271. doi: 10.1038/s41598-025-99395-w. Sci Rep. 2025. PMID: 40312440 Free PMC article.
-
Investigation of the Mechanism of Complement System in Diabetic Nephropathy via Bioinformatics Analysis.J Diabetes Res. 2021 May 24;2021:5546199. doi: 10.1155/2021/5546199. eCollection 2021. J Diabetes Res. 2021. PMID: 34124269 Free PMC article.
Cited by
-
Inhibition of complement system-related gene ITGB2 attenuates epithelial-mesenchymal transition and inflammation in diabetic nephropathy.Eur J Med Res. 2025 Feb 8;30(1):87. doi: 10.1186/s40001-025-02323-x. Eur J Med Res. 2025. PMID: 39920798 Free PMC article.
References
-
- Anders HJ, Huber TB, Isermann B, et al. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14:361–77. - PubMed
-
- American Diabetes Association. Cardiovascular disease and risk management: standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44:S125–50. - PubMed
-
- Kanwar YS, Wada J, Sun L, et al. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med. 2008;233:4–11. - PubMed
-
- Daniel F, Karin AMJD, Mark EC. Diabetic nephropathy: diagnosis and treatment. Nat Rev Endocrinol. 2013;9:713–23. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous